Home LiteratureArticle Details
PMID: 6979554 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

The Journal of clinical investigation ·Vol. 69 ·No. 6 ·1982-06-00 ·Pages 1388-92

Alcocer-Varela J, Alarcón-Segovia D

Abstract

We studied the production of and response to interleukin-2 (IL-2) by peripheral blood T lymphocytes from 19 systemic lupus erythematosus (SLE) patients who received no treatment at the time they were studied. Eight had active disease and the rest were in remission. Results were compared with those obtained in 12 healthy subjects of similar age. T cells from SLE patients, whether activated with phytohemagglutinin or in autologous mixed lymphocyte reactions, were found to yield little IL-2, to have a low response to IL-2 from its own, or other sources, and to absorb IL-2 poorly, IL-2 produced by SLE cells, albeit scant, was absorbed normally by activated T cells from normal subjects. Our findings may contribute to the understanding of the immunoregulatory defect in SLE.

MeSH Terms
Absorption Adult Cells, Cultured Female Humans Immunoglobulin G/biosynthesis Immunoglobulin M/biosynthesis Interleukin-2/biosynthesis,metabolism,pharmacology Lupus Erythematosus, Systemic/immunology Lymphocyte Activation Lymphokines/biosynthesis Male Middle Aged Phytohemagglutinins/pharmacology T-Lymphocytes/immunology
Chemicals
Immunoglobulin G Immunoglobulin M Interleukin-2 Lymphokines Phytohemagglutinins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Alcocer-Varela J
Alarcón-Segovia D
References (22)
22 references, click to expand
  1. Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies.
    Clin Exp Immunol. 1977 Jan;27(1):100-10 PMID: 849643
  2. T cell growth factor: parameters of production and a quantitative microassay for activity.
    J Immunol. 1978 Jun;120(6):2027-32 PMID: 307029
  3. The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus.
    J Clin Invest. 1979 Jan;63(1):151-3 PMID: 153913
  4. Decreased circulating thymus-derived cells with receptors for the Fc portion of immunoglobulin G in systemic lupus erythematosus.
    J Clin Invest. 1978 Dec;62(6):1390-4 PMID: 311785
  5. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
    J Clin Invest. 1979 Mar;63(3):536-9 PMID: 311787
  6. Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes.
    J Immunol. 1979 May;122(5):1633-8 PMID: 109511
  7. Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into Tgamma lymphocytes causing their deletion and the abrogation of suppressor function.
    J Immunol. 1979 May;122(5):1855-62 PMID: 376727
  8. Glucocorticoids and immune responses.
    Arthritis Rheum. 1979 Nov;22(11):1246-56 PMID: 389249
  9. Continued growth of functional human T lymphocytes: production of human T-cell growth factor.
    Cell Immunol. 1980 May;51(2):390-401 PMID: 6966190
  10. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
    J Clin Invest. 1980 Jul;66(1):141-8 PMID: 6447163
  11. Heterogeneity of the spontaneously expanded and mitogen-induced generation of suppressor cell function of T cells on B cells in systemic lupus erythematosus.
    Arthritis Rheum. 1980 Sep;23(9):1004-9 PMID: 6998486
  12. Cellular origins and targets of costimulator (IL2).
    Immunol Rev. 1980;51:157-75 PMID: 7000669
  13. Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.
    J Clin Invest. 1980 Nov;66(5):1171-4 PMID: 7000827
  14. Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.
    Arthritis Rheum. 1980 Nov;23(11):1274-81 PMID: 6969594
  15. Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes.
    Blood. 1981 Mar;57(3):379-94 PMID: 7006707
  16. Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.
    J Clin Invest. 1981 Apr;67(4):937-42 PMID: 6970755
  17. Human postthymic precursor cells in health and disease. II. Their loss and dysfunction in systemic lupus erythematosus and their partial correction with serum thymic factor.
    J Clin Lab Immunol. 1981 Mar;5(2):71-80 PMID: 6971333
  18. T cell growth factor abrogates concanavalin A-induced suppressor cell function.
    J Exp Med. 1981 May 1;153(5):1360-5 PMID: 6454746
  19. The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.
    J Immunol. 1981 Oct;127(4):1323-8 PMID: 6456304
  20. Immune responses to hapten-modified self and their regulation in normal individuals and patients with SLE.
    J Immunol. 1981 Oct;127(4):1643-52 PMID: 6456309
  21. Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.
    J Immunol. 1981 Nov;127(5):1936-40 PMID: 6975304
  22. Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.
    J Exp Med. 1981 Nov 1;154(5):1671-80 PMID: 6975351
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1982-06-00
Pages
1388-92
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC370212
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]